• Home
  • keyboard_arrow_right Featured
  • keyboard_arrow_rightPodcasts
  • keyboard_arrow_right
  • keyboard_arrow_right Dr. Cook Roundtable Q&A Series – Current IRB Submission Process for COVID-19: Part 3 (Recorded May 6, 2020)
play_arrow

Featured

Dr. Cook Roundtable Q&A Series – Current IRB Submission Process for COVID-19: Part 3 (Recorded May 6, 2020)

Dr. Matthew Cook May 11, 2020 12


Background
share close

Tune in to this podcast Q&A series with Dr. Cook and other doctors as they discuss the current state of Institutional Review Board (IRB) submissions for COVID, the benefits of regenerative therapies to treat the inflammation and pulmonary symptoms, and industry updates specifically around peptides as potential treatment options.

BioReset Medical is currently completing an IRB application process. Our goal is to validate the approaches that we are using to (a) prevent transmission of the corona virus (b) treat active cases and (c) help manage the long-term complications that affect patients after an acute infection. There are several modalities that we’ve been studying, including: 

  • Ozone 
  • Lysine
  • intravenous Vitamin C
  • Intravenous glutathione 
  • Peptides
  • Regenerative medicine including exosomes and stem cell therapy
Rate it
Previous episode

Post comments

This post currently has no comments.

Leave a reply

Your email address will not be published. Required fields are marked *